Osteoarthritis Trial, Recruiting NCT07323342 Sponsor: Cao Kim Xoa Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07323342
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 45 and 75 years old, of any gender
  • People who have been diagnosed with primary knee osteoarthritis using a specific set of medical guidelines called the ACR 1991 criteria
  • People of Vietnamese background
  • People who have agreed in writing to take part in the study
  • People whose full-length standing leg X-rays show that the leg's load-bearing angle is off by less than 10 degrees (confirm with trial site)
  • People whose body weight falls within a moderate range relative to their height — specifically, a BMI between 18.5 and 35 kg/m²

Who may not be able to join:

  • People who currently have an active infection in a joint or anywhere else in the body
  • People who have other joint conditions such as rheumatoid arthritis, gout, cancer-related joint disease, or a significant previous knee injury
  • People who are currently experiencing a serious acute illness such as a high fever, heart attack, or pneumonia
  • People who have taken anti-inflammatory pain medicines (such as ibuprofen or similar drugs) within the 10 days before enrolling, or who have had a steroid injection into the knee within the past 3 months
  • People who have fluid build-up in the knee joint at the time of their screening appointment
  • People who have a known allergy or sensitivity to hyaluronic acid

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nam Anh Tang Ha, MD, PhD, Xuong Khop Viet Clinic

Phone: +84 987111194

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cao Kim Xoa
Registry
ClinicalTrials.gov
Start date
5 May 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Change from baseline in WOMAC total score; Change from baseline in pain intensity at rest measured by Visual Analog Scale (VAS); Change from baseline in pain intensity during movement measured by Visual Analog Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov